Gérard Zalcman
Centre de Recherche Institut Curie
422 papers found
Refreshing results…
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study
UploadMissing publications? Search for publications with a matching author name.